Crossmark Global Holdings Inc. trimmed its position in Barclays PLC (NYSE:BCS - Free Report) by 44.4% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 754,930 shares of the financial services provider's stock after selling 603,544 shares during the period. Crossmark Global Holdings Inc.'s holdings in Barclays were worth $11,596,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Callan Capital LLC boosted its stake in Barclays by 16.5% in the first quarter. Callan Capital LLC now owns 23,226 shares of the financial services provider's stock valued at $357,000 after acquiring an additional 3,296 shares during the last quarter. Concurrent Investment Advisors LLC boosted its stake in Barclays by 63.5% in the first quarter. Concurrent Investment Advisors LLC now owns 33,537 shares of the financial services provider's stock valued at $515,000 after acquiring an additional 13,025 shares during the last quarter. Wayfinding Financial LLC purchased a new position in Barclays in the first quarter valued at about $46,000. Checchi Capital Advisers LLC boosted its stake in Barclays by 7.1% in the first quarter. Checchi Capital Advisers LLC now owns 19,673 shares of the financial services provider's stock valued at $302,000 after acquiring an additional 1,311 shares during the last quarter. Finally, Aaron Wealth Advisors LLC boosted its stake in Barclays by 4.0% in the first quarter. Aaron Wealth Advisors LLC now owns 32,120 shares of the financial services provider's stock valued at $493,000 after acquiring an additional 1,240 shares during the last quarter. 3.39% of the stock is owned by institutional investors.
Barclays Stock Performance
Shares of BCS stock traded down $0.39 during trading on Friday, reaching $18.42. 12,656,719 shares of the company's stock traded hands, compared to its average volume of 15,088,810. The company has a market capitalization of $65.21 billion, a P/E ratio of 9.35, a PEG ratio of 0.46 and a beta of 1.10. The company has a current ratio of 1.39, a quick ratio of 1.39 and a debt-to-equity ratio of 5.75. The firm's 50-day moving average is $17.70 and its 200 day moving average is $15.78. Barclays PLC has a 1 year low of $10.23 and a 1 year high of $18.82.
Barclays (NYSE:BCS - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $0.65 EPS for the quarter, beating analysts' consensus estimates of $0.61 by $0.04. The company had revenue of $10.32 billion for the quarter, compared to analysts' expectations of $8.37 billion. Barclays had a net margin of 21.27% and a return on equity of 8.04%. Equities research analysts expect that Barclays PLC will post 2 EPS for the current year.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded shares of Barclays from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th.
Read Our Latest Stock Report on BCS
Barclays Profile
(
Free Report)
Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK and Barclays International division segments. It offers financial services, such as retail banking, credit cards, wholesale banking, investment banking, wealth management, and investment management services.
Read More

Before you consider Barclays, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Barclays wasn't on the list.
While Barclays currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.